Warning against increasing cases of cutaneous leishmaniasis and unavailability of meglumine in Pakistan
Article Sidebar
Main Article Content
Abstract
Leishmaniasis is the protozoal disease transmitted by sandfly vectors. Leishmaniasis due to the increase in its incidence is becoming a health concern globally. According to WHO approximately 0.5 million cases of leishmaniasis occur every year with 21,000 out of them being from Pakistan. A notification alert has been released by Directorate General Of Health Services Punjab on 5th June 2023, raising concern against the alarming increase in cases of Cutaneous Leishmaniasis in Punjab.
Intralesional Meglumine Antimoniate is the drug of choice for treating cutaneous leishmaniasis and the LTE highlights the issue of its unavailability in Pakistan and how that is affecting patient care. This needs to be brought to light and taken notice of by the higher authorities.
Article Details
Work published in KMUJ is licensed under a
Creative Commons Attribution 4.0 License
Authors are permitted and encouraged to post their work online
(e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
References
Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One 2012;7(5):e35671. https://doi.org/10.1371/journal.pone.0035671
Ihsanullah M, Yousuf MJ, Ahmad N, Masood Z, Majeed S, Hassan HU, et al. Prevalence of cutaneous leishmaniasis in the largest populated city Karachi, Pakistan. Braz J Biol 2021;83:e247583. https://doi.org/10.1590/1519-6984.247583
Primary and Secondary Healthcare Department, Government of Punjab, Pakistan. Communicable Disease Control (CDC) Program and Epidemics Prevention and Control Program in Punjab. Accessed on: August 24, 2023. Available from URL: https://pshealthpunjab.gov.pk/Home/VerticalProgramChilds/46
Yesilova Y, Surucu HA, Ardic N, Aksoy M, Yesilova A, Oghumu S, et al. Meglumine antimoniate is more effective than sodium stibogluconate in the treatment of cutaneous leishmaniasis. J Dermatolog Treat 2016;27(1):83-7. https://doi.org/10.3109/09546634.2015.1054778
Arif M, Kalsoom, Shah AA, Badshah M, Hasan F, Rehman AU, et al. Positivity, diagnosis and treatment follow-up of cutaneous leishmaniasis in war-affected areas of Bajaur, Pakistan. Parasitol Res 2022;121(3):991-8. https://doi.org/10.1007/s00436-022-07438-2